Fresenius Total Assets vs Non Current Liabilities Total Analysis
FMS Stock | USD 20.97 0.69 3.19% |
Fresenius Medical financial indicator trend analysis is much more than just examining Fresenius Medical Care latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Fresenius Medical Care is a good investment. Please check the relationship between Fresenius Medical Total Assets and its Non Current Liabilities Total accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fresenius Medical Care. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
Total Assets vs Non Current Liabilities Total
Total Assets vs Non Current Liabilities Total Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Fresenius Medical Care Total Assets account and Non Current Liabilities Total. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Fresenius Medical's Total Assets and Non Current Liabilities Total is 0.94. Overlapping area represents the amount of variation of Total Assets that can explain the historical movement of Non Current Liabilities Total in the same time period over historical financial statements of Fresenius Medical Care, assuming nothing else is changed. The correlation between historical values of Fresenius Medical's Total Assets and Non Current Liabilities Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Assets of Fresenius Medical Care are associated (or correlated) with its Non Current Liabilities Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Current Liabilities Total has no effect on the direction of Total Assets i.e., Fresenius Medical's Total Assets and Non Current Liabilities Total go up and down completely randomly.
Correlation Coefficient | 0.94 |
Relationship Direction | Positive |
Relationship Strength | Very Strong |
Total Assets
Total assets refers to the total amount of Fresenius Medical assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Fresenius Medical Care books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Non Current Liabilities Total
Most indicators from Fresenius Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Fresenius Medical Care current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fresenius Medical Care. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. At this time, Fresenius Medical's Tax Provision is comparatively stable compared to the past year. Enterprise Value Over EBITDA is likely to gain to 6.94 in 2024, whereas Selling General Administrative is likely to drop slightly above 3 B in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 5.1B | 5.3B | 4.9B | 3.7B | Total Revenue | 17.6B | 19.4B | 19.5B | 11.4B |
Fresenius Medical fundamental ratios Correlations
Click cells to compare fundamentals
Fresenius Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Fresenius Medical fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Common Stock Shares Outstanding | 302.7M | 294.3M | 293.1M | 293.2M | 293.4M | 405.8M | |
Total Assets | 32.9B | 31.7B | 34.4B | 35.8B | 33.9B | 18.7B | |
Short Long Term Debt Total | 13.8B | 12.4B | 13.3B | 13.2B | 12.1B | 6.2B | |
Other Current Liab | 2.7B | 3.0B | 3.3B | 3.4B | 3.6B | 3.8B | |
Total Current Liabilities | 7.0B | 6.2B | 7.3B | 6.5B | 6.1B | 3.6B | |
Total Stockholder Equity | 13.2B | 12.3B | 14.0B | 15.4B | 13.6B | 7.8B | |
Property Plant And Equipment Net | 8.5B | 4.1B | 4.3B | 4.2B | 7.5B | 7.8B | |
Net Debt | 12.8B | 11.3B | 11.8B | 11.9B | 10.6B | 5.7B | |
Retained Earnings | 9.5B | 10.3B | 10.8B | 10.7B | 10.9B | 11.5B | |
Accounts Payable | 835.2M | 827.4M | 857.5M | 931.3M | 885.1M | 550.9M | |
Cash | 1.0B | 1.1B | 1.5B | 1.3B | 1.4B | 1.5B | |
Non Current Assets Total | 25.8B | 24.4B | 26.4B | 27.6B | 25.2B | 13.8B | |
Non Currrent Assets Other | 752.5M | 4.8B | 5.2B | 5.0B | 223.6M | 212.4M | |
Cash And Short Term Investments | 1.1B | 1.2B | 1.6B | 1.4B | 1.5B | 1.6B | |
Net Receivables | 4.0B | 3.6B | 3.9B | 4.0B | 4.1B | 2.6B | |
Common Stock Total Equity | 308.1M | 307.9M | 304.4M | 292.9M | 336.8M | 304.7M | |
Liabilities And Stockholders Equity | 32.9B | 31.7B | 34.4B | 35.8B | 33.9B | 18.7B | |
Non Current Liabilities Total | 12.7B | 13.2B | 13.1B | 13.8B | 13.0B | 7.2B | |
Inventory | 1.7B | 1.9B | 2.0B | 2.3B | 2.2B | 2.3B | |
Other Current Assets | 320.7M | 455.7M | 342.9M | 351.1M | 332.6M | 348.1M | |
Other Stockholder Equity | 4.5B | 4.0B | 4.2B | 4.8B | 3.4B | 3.2B | |
Total Liab | 19.7B | 19.4B | 20.4B | 20.3B | 19.1B | 10.8B | |
Property Plant And Equipment Gross | 8.5B | 8.2B | 4.3B | 4.2B | 17.9B | 17.0B | |
Total Current Assets | 7.2B | 7.3B | 8.0B | 8.2B | 8.7B | 4.9B | |
Accumulated Other Comprehensive Income | (1.0B) | (2.2B) | (1.3B) | (388.5M) | (975.2M) | (926.4M) | |
Short Term Debt | 3.3B | 1.7B | 2.6B | 2.0B | 1.6B | 1.1B | |
Intangible Assets | 1.4B | 1.4B | 1.5B | 1.5B | 1.4B | 1.7B | |
Common Stock | 304.4M | 292.9M | 293.0M | 293.4M | 337.4M | 258.6M | |
Current Deferred Revenue | 201.0M | 606.3M | 518.0M | 105.7M | 85.8M | 81.5M | |
Other Liab | 2.1B | 2.5B | 2.4B | 2.7B | 3.1B | 3.2B | |
Other Assets | 1.1B | 1.1B | 1.2B | 1.1B | 1.3B | 1.4B | |
Long Term Debt | 6.5B | 6.8B | 6.6B | 7.2B | 7.0B | 5.7B | |
Property Plant Equipment | 8.5B | 8.2B | 8.6B | 8.3B | 9.6B | 10.1B | |
Good Will | 14.0B | 13.0B | 14.4B | 15.8B | 14.7B | 13.9B | |
Short Term Investments | 133.3M | 161.7M | 136.4M | 170.0M | 136.3M | 140.2M | |
Net Tangible Assets | (3.5B) | (3.1B) | (3.1B) | (3.3B) | (3.8B) | (4.0B) | |
Long Term Investments | 696.9M | 761.1M | 786.9M | 773.7M | 1.3B | 853.1M | |
Short Long Term Debt | 2.6B | 1.1B | 1.9B | 1.4B | 944.6M | 1.7B |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Fresenius Medical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Fresenius Medical's short interest history, or implied volatility extrapolated from Fresenius Medical options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fresenius Medical Care. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Complementary Tools for Fresenius Stock analysis
When running Fresenius Medical's price analysis, check to measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Transaction History View history of all your transactions and understand their impact on performance | |
Commodity Directory Find actively traded commodities issued by global exchanges |
Is Fresenius Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fresenius Medical. If investors know Fresenius will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fresenius Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.353 | Dividend Share 1.19 | Earnings Share 0.91 | Revenue Per Share 33.1505 | Quarterly Revenue Growth (0) |
The market value of Fresenius Medical Care is measured differently than its book value, which is the value of Fresenius that is recorded on the company's balance sheet. Investors also form their own opinion of Fresenius Medical's value that differs from its market value or its book value, called intrinsic value, which is Fresenius Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fresenius Medical's market value can be influenced by many factors that don't directly affect Fresenius Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fresenius Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Fresenius Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fresenius Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.